Viewing Study NCT00440466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-07 @ 9:58 AM
Study NCT ID: NCT00440466
Status: COMPLETED
Last Update Posted: 2014-04-21
First Post: 2007-02-26
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia View
None Renal Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anemia View
None Reduction in the number of erythrocytes View
None Hemoglobin low level View
None Red blood cell deficiency View
None Procrit View
None Epoetin alfa View
None Chronic kidney disease View